Medicine for heavy kids helps hearts and sugar levels
GLP-1 receptor agonists in obesity treatment: Effects on cardiometabolic variables and cardiovascular disease.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
Weight-loss drugs are reducing cardiovascular mortality and major heart events
Historically, many weight-loss drugs raised heart risks; now, some are actively protecting the heart—flipping the script on obesity pharmacotherapy.
Practical Takeaways
People with obesity and heart or metabolic risks should discuss GLP-1 receptor agonists with their doctor as a potential treatment option.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
Weight-loss drugs are reducing cardiovascular mortality and major heart events
Historically, many weight-loss drugs raised heart risks; now, some are actively protecting the heart—flipping the script on obesity pharmacotherapy.
Practical Takeaways
People with obesity and heart or metabolic risks should discuss GLP-1 receptor agonists with their doctor as a potential treatment option.
Publication
Related Content
Claims (5)
Medicines like liraglutide, semaglutide, and tirzepatide can help people with extra weight lose pounds and improve their blood sugar, liver health, cholesterol, and blood pressure.
These diabetes and weight-loss drugs might help prevent or lessen health problems caused by obesity, like heart disease or diabetes.
People with obesity and heart failure who take tirzepatide might have a lower chance of dying from heart problems and feel better with fewer heart failure symptoms.
If you're someone with obesity, taking a weekly shot called semaglutide might help lower your chances of having serious heart problems like heart attacks, strokes, or heart-related death, and could also reduce heart failure symptoms.
GLP-1 drugs are changing the game for treating obesity because they help people lose more weight and improve heart and metabolic health better than older treatments.